Using AI to analyze the superficial femoral artery for better treatment of artery disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the technical feasibility of using an artificial intelligence algorithm to perform histological segmentation of the superficial femoral artery segment (FPAS) from preoperative CT scans. The research focuses on differentiating various types of atheromatous plaques that can affect treatment outcomes in patients with peripheral artery disease. By analyzing the anatomical and pathological characteristics of these plaques, the study seeks to provide initial data that could support a larger scale study to validate the diagnostic capabilities of this automated segmentation approach.

Why it matters

Who can join: the full rules

Inclusion criteria:

* Male or female of legal age
* Subject with a planned transfemoral amputation in the vascular surgery department of the Hôpitaux Universitaires de Strasbourg as standard care
* Subject with a CT as part of standard care
* Subject who has given his/her non-opposition to participate in the study

Exclusion criteria:

\- Impossible to give the subject informed information (subject in emergency situation, difficulties in understanding)

Where it's running

• Hôpitaux Universitaire de Strasbourg
  Strasbourg, Bas-Rhin, France Recruiting

Study contacts

• Study coordinator: Salomé KUNTZ, Doctor
• Email: salome.kuntz@chru-strasbourg.fr
• Phone: +31 3 69 55 01 98

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Antiplatelet-Only versus Antiplatelet plus Low-Dose Rivaroxaban after Heart Events

  In adults 65 or older with prior heart events and certain arterial diseases, this study tests whether continuing clopidogrel alone is no worse than adding low-dose rivaroxaban to aspirin-based therapy.

  Recruiting Phase 4 Seoul National University Bundang Hospital · Seongnam-si, Gyeonggi-do · NCT07796217

• Home-based Pedal Exerise Therapy for Moderate-to-Severe PAD

  This pilot study tests whether a 12-week home-based pedal exerciser program, guided remotely, can help adults with moderate-to-severe PAD improve walking and function.

  Recruiting Laval University · Lévis, Quebec · NCT07655206

• Super-resolution ultrasound imaging for peripheral artery disease

  This project will test whether super-resolution contrast ultrasound can reveal small-vessel problems in adults with or without peripheral artery disease.

  Recruiting Peking University First Hospital · Beijing, Beijing Municipality · NCT07374601

• Obstructive sleep apnea prevalence in people with peripheral artery disease

  This project will test how common obstructive sleep apnea is in adults with peripheral artery disease by using sleep polygraphy during routine care.

  Recruiting Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · Toulon, Var · NCT07283289

• Using wearable activity trackers and a mobile app to help people with peripheral artery disease walk better

  This project will test whether a personalized home walking program guided by wearable activity trackers and automatic feedback can help people with peripheral artery disease walk as well as supervised exercise sessions.

  Recruiting at 2 sites Chinese University of Hong Kong · Hong Kong, Hong Kong and 1 other locations · NCT07012070

• Evaluating a Paclitaxel Coated Balloon for Treating Atherosclerosis in Leg Arteries

  This study is testing a special balloon treatment to see if it can safely improve blood flow and reduce symptoms in people with blocked leg arteries due to peripheral artery disease.

  Recruiting at 2 sites Balton Sp.zo.o. · Chrzanów, Malopolska and 2 other locations · NCT06734221

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.